Dr. Maria T. Grosse-Perdekamp
Claim this profileCarle Cancer Center
Expert in Breast Cancer
Studies Cancer
29 reported clinical trials
60 drugs studied
About Maria T. Grosse-Perdekamp
Education:
- Earned an MD (Doctor of Medicine), with the institution not specified.
- Completed a Residency in Radiation Oncology at Carle Foundation Hospital in 2019.
- Undertook a Fellowship in Brachytherapy at Carle Foundation Hospital in 2020.
Experience:
- Currently serves as a Radiation Oncologist at Carle Cancer Center.
Area of expertise
1Breast Cancer
Global LeaderHER2 positive
HER2 negative
Stage II
2Cancer
Stage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Maria T. Grosse-Perdekamp is currently running
Ribociclib vs. Palbociclib
for Breast Cancer
HARMONIA is an international, multicenter, randomized, open-label and phase III study. The primary objective of this study is to demonstrate that the combination of ribociclib with endocrine therapy (letrozole or fulvestrant) is superior to palbociclib with endocrine therapy (letrozole or fulvestrant) in prolonging progression-free survival in patients with advanced HR+/HER2- and HER2-E breast cancer. The study will enroll approximately 456 patients with HER2-E disease from approximately 95 sites worldwide. In addition, the HARMONIA trial will include an exploratory cohort of patients with HR+/HER2- and Basal-like disease treated with paclitaxel +/- Tislelizumab. This cohort does not have a predefined sample size and the objective is only exploratory, given the suggested lack of efficacy of the combinations of hormone therapy and CDK4/6 inhibitors in this subgroup of patients. Enrolment into the basal-like cohort will stop once the HER2-E disease cohort is fully enrolled.
Recruiting4 awards Phase 311 criteria
Bupropion
for Fatigue in Breast Cancer Survivors
This phase III trial studies how well bupropion works in reducing cancer related fatigue in cancer survivors. Bupropion is a drug that is used to treat depression, as well as to help people quit smoking. Cancer and its treatment can cause fatigue. Giving bupropion may improve cancer related fatigue in cancer survivors.
Recruiting1 award Phase 38 criteria
More about Maria T. Grosse-Perdekamp
Clinical Trial Related2 years of experience running clinical trials · Led 29 trials as a Principal Investigator · 16 Active Clinical TrialsTreatments Maria T. Grosse-Perdekamp has experience with
- Paclitaxel
- Biospecimen Collection
- Atezolizumab
- Carboplatin
- Docetaxel
- Rituximab
Breakdown of trials Maria T. Grosse-Perdekamp has run
Breast Cancer
Cancer
Ovarian Cancer
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maria T. Grosse-Perdekamp specialize in?
Maria T. Grosse-Perdekamp focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are HER2 negative.
Is Maria T. Grosse-Perdekamp currently recruiting for clinical trials?
Yes, Maria T. Grosse-Perdekamp is currently recruiting for 15 clinical trials in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Maria T. Grosse-Perdekamp has studied deeply?
Yes, Maria T. Grosse-Perdekamp has studied treatments such as Paclitaxel, Biospecimen Collection, Atezolizumab.
What is the best way to schedule an appointment with Maria T. Grosse-Perdekamp?
Apply for one of the trials that Maria T. Grosse-Perdekamp is conducting.
What is the office address of Maria T. Grosse-Perdekamp?
The office of Maria T. Grosse-Perdekamp is located at: Carle Cancer Center, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.